Organization · Micro VC
Bold Capital
Bold Capital is a micro venture capital firm based in São Paulo, Brazil, specializing in early-stage investments in healthtech startups. The firm focuses on leveraging technology-driven solutions to enhance healthcare outcomes.
Overview
What Bold Capital does
What Bold Capital is
Bold Capital is a micro venture capital firm based in São Paulo, Brazil, specializing in early-stage investments in healthtech startups. The firm focuses on leveraging technology-driven solutions to enhance healthcare outcomes.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Micro VC
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find Bold Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Bold Capital as a funder
Investment thesis
Bold Capital leverages early-stage HealthTech startups through first check and seed investments, focusing on extraordinary founders building solutions that are at least 10x better than existing market offerings using exponential technologies.
Focus narrative
Bold Capital invests in early-stage startups within the healthtech sector, providing funding from the first check to seed money. The firm is particularly interested in startups that demonstrate potential for market leadership and utilize exponential technologies. Key areas of interest include AI, Big Data, telemedicine, IoT for monitoring, and blockchain for patient-centered medical records.
Value beyond capital
Bold Capital adds value to its portfolio companies through strategic mentorship, connections to subsequent funding rounds, and partnerships with hospital networks for product validation. The firm emphasizes founder-operator support to de-risk early-stage product development.
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- Br · Latam
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 5
- Recorded notable exits
- IntuitiveCare
Portfolio context
Bold Capital's portfolio includes notable companies such as: 1. Biosens - Develops rapid tests for point-of-care devices using graphene-based reactive strips. 2. Cor.Sync - Offers a desktop laboratory for rapid cardiovascular disease diagnostics. 3. IntuitiveCare - Focused on improving interoperability in healthcare systems, acquired by Arcadea in 2025. 4. IAssist - Provides predictive solutions for early tumor diagnosis using AI. 5. Viziomed - Aggregates AI algorithms for medical imaging diagnostics.
Common questions
What to know about Bold Capital
Upseed classifies Bold Capital under the Micro VC organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.